Toshihiro Soma

Title: Innovations of Toshihiro Soma in Mesenchymal Stromal Cell Research

Introduction

Toshihiro Soma is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of biomedical research, particularly in the area of mesenchymal stromal cells (MSCs). With a total of two patents to his name, his work focuses on innovative methods for producing and preserving these valuable cells.

Latest Patents

Soma's latest patents include a method for producing an amniotic mesenchymal stromal cell composition and a method for cryopreserving the same. The objective of his invention is to provide a convenient and aseptic method for separating high-purity amnion-derived MSCs through a single enzyme treatment. The process involves treating the amnion with collagenase and thermolysin and/or dispase, followed by filtering the enzyme-treated amnion through a mesh. Additionally, his patents encompass a therapeutic agent that utilizes the mesenchymal stromal cell composition for treating various diseases, including graft-versus-host disease, inflammatory bowel disease, systemic lupus erythematosus, liver cirrhosis, and radiation enteritis.

Career Highlights

Throughout his career, Toshihiro Soma has worked with esteemed organizations such as the National Cerebral and Cardiovascular Center and the Foundation for Biomedical Research and Innovation at Kobe. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Soma has collaborated with notable colleagues, including Kenichi Yamahara and Akihiko Taguchi. These partnerships have further enriched his research endeavors and have played a role in the development of his innovative patents.

Conclusion

Toshihiro Soma's work in the field of mesenchymal stromal cells represents a significant advancement in biomedical research. His innovative methods and collaborations highlight the importance of teamwork in achieving breakthroughs in science.